產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-CLDND1抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CLDND1抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CLDND1
Cat. Number:
Anti-CLDND1抗體KL-6683R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
CLDND1 is a 253 amino acid multi-pass membrane protein that is expressed at high levels in ***** brain and at lower levelsAnti-CLDND1抗體 in ***** heart. Existing as two alternatively spliced isoforms, CLDND1 is encoded by a gene that maps to human chromosome 3, which houses over 1,100 genes, including a chemokine receptor (CKR) gene cluster and a variety of human cancer-related gene loci. Key tumor suppressing genes on chromosome 3 include those that encode the apoptosis mediator RASSF1, the cell migration regulator HYAL1 and the angiogenesis suppressor SEMA3B. Marfan Syndrome, porphyria, von Hippel-Lindau syndrome, osteogenesis imperfecta and Charcot-Marie-Tooth Disease are a few of the numerous genetic diseases associated with chromosome 3.
Also known as:
C3orf4; Chromosome 3 Anti-CLDND1抗體open reading frame 4; Claudin domain containing 1; Claudin domain containing 1 protein; Membrane protein GENX3745; CLDN1_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CLDND1.
●
Predicted Molecular Weight: 29kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-CLDND1抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutionsAnti-CLDND1抗體must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutionsAnti-CLDND1抗體must be determined by the end user.
kl048Bo01 抑制素βE(INHβE)多克隆抗體 Polyclonal Antibody to Inhibin Beta E (INHbE)
kl048Mu01 抑制素βE(INHβE)多克隆抗體 Polyclonal Antibody to Inhibin Beta E (INHbE)
kl048Mu02 抑制素βE(INHβE)多克隆抗體 Polyclonal Antibody to Inhibin Beta E (INHbE)
kl049Eq01 干擾素γ(IFNγ)多克隆抗體 Polyclonal Antibody to Interferon Gamma (IFNg)
kl049Mu02 干擾素γ(IFNγ)多克隆抗體 Polyclonal Antibody to Interferon Gamma (IFNg)
kl050Mu02 胰島素樣生長(zhǎng)因子1(IGF1)多克隆抗體 Polyclonal Antibody to Insulin Like Growth Factor 1 (IGF1)
kl051Mu02 胰島素樣生長(zhǎng)因子2(IGF2)多克隆抗體 Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2)
kl052Mu02 胰島素樣生長(zhǎng)因子結(jié)合蛋白1(IGFBP1)多克隆抗體 Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 1 (IGFBP1)
kl053Ga01 胰島素樣生長(zhǎng)因子結(jié)合蛋白2(IGFBP2)多克隆抗體 Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 2 (IGFBP2)
kl054Mu02 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)多克隆抗體 Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 3 (IGFBP3)
kl055Mu02 胰島素樣生長(zhǎng)因子結(jié)合蛋白4(IGFBP4)多克隆抗體 Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 4 (IGFBP4)
kl056Mu02 白介素10(IL10)多克隆抗體 Polyclonal Antibody to Interleukin 10 (IL10)
kl057Mu02 白介素11(IL11)多克隆抗體 Polyclonal Antibody to Interleukin 11 (IL11)
kl058Mu02 白介素12B(IL12B)多克隆抗體 Polyclonal Antibody to Interleukin 12B (IL12B)
kl059Mu02 白介素12A(IL12A)多克隆抗體 Polyclonal Antibody to Interleukin 12A (IL12A)
kl060Mu02 白介素13(IL13)多克隆抗體 Polyclonal Antibody to Interleukin 13 (IL13)
kl061Mu02 白介素15(IL15)多克隆抗體 Polyclonal Antibody to Interleukin 15 (IL15)
kl063Mu02 白介素17(IL17)多克隆抗體 Polyclonal Antibody to Interleukin 17 (IL17)
kl064Mu02 白介素18(IL18)多克隆抗體 Polyclonal Antibody to Interleukin 18 (IL18)
